Leverone Jason A. — SEC insider filings
SEC reporting owner CIK 1692747. 12 insider filings on record with FilingPulse; latest filed 2026-09-23.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2021-01-20 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 7 filings — 4,936 shares, $15,073 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 1,844 shares @ $2.67 ($4,925) in OnKure Therapeutics, Inc., filed 2025-04-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | Chief Financial Officer | 11 | — | 8 legs · 4,936 sh · $15,073 | 13 |
| Viridian Therapeutics, Inc.\DE (VRDN) | Chief Financial Officer | 1 | — | — | 1 |
Insider filings — Leverone Jason A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-23 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 302 @ $2.97 | EDGAR |
| 2026-08-11 | 4 | OnKure Therapeutics, Inc. (OKUR) | Grant/award (A): 50,000 (derivative) @ $0 · Disposition to issuer (D): 5,781 (derivative) · Grant/award (A): 5,781 (derivative) · Disposition to issuer (D): 5,322 (derivative) · Grant/award (A): 5,322 (derivative) · Disposition to issuer (D): 130,611 (derivative) · +1 more | EDGAR |
| 2026-06-24 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 303 @ $4.40 | EDGAR |
| 2026-04-03 | 4 | OnKure Therapeutics, Inc. (OKUR) | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 301 @ $4.16 | EDGAR |
| 2025-12-23 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 302 @ $2.97 | EDGAR |
| 2025-09-24 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 303 @ $2.62 | EDGAR |
| 2025-06-25 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 303 @ $2.38 | EDGAR |
| 2025-04-08 | 4 | OnKure Therapeutics, Inc. (OKUR) | Sale (S): 1,278 @ $3.33 · Sale (S): 1,844 @ $2.67 | EDGAR |
| 2025-01-29 | 4 | OnKure Therapeutics, Inc. (OKUR) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-10-08 | 4 | OnKure Therapeutics, Inc. (OKUR) | Grant/award (A): 16,331 · Grant/award (A): 5,781 (derivative) · Grant/award (A): 5,322 (derivative) · Grant/award (A): 130,611 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 311,785 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1692747 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs